These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 15220039)
21. Confusing drug packaging contributes to death of 15 children. Pakenham-Walsh N; Ana J Lancet Glob Health; 2014 Nov; 2(11):e634. PubMed ID: 25442687 [No Abstract] [Full Text] [Related]
22. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study. Bouvier JM; Rabot D; Herrero G J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124 [TBL] [Abstract][Full Text] [Related]
23. A population-based analysis of the class effect of beta-blockers after myocardial infarction. Rinfret S; Abrahamowicz M; Tu J; Humphries K; Eisenberg MJ; Richard H; Austin PC; Pilote L Am Heart J; 2007 Feb; 153(2):224-30. PubMed ID: 17239680 [TBL] [Abstract][Full Text] [Related]
24. [Comparative study of acebutolol and propranolol in the treatment of arterial hypertension]. Tacquet A Nouv Presse Med; 1975 Dec; 4(46 Suppl):3294-6. PubMed ID: 768913 [TBL] [Abstract][Full Text] [Related]
30. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives. Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428 [TBL] [Abstract][Full Text] [Related]
31. Rotarix packaging: labelling and packaging change. More improvement needed. Confusing oral syringe still available. Prescrire Int; 2008 Oct; 17(97):196. PubMed ID: 19537308 [No Abstract] [Full Text] [Related]
32. Beta-adrenergic blockade during severe ischemia. Coetzee A; Coetzee G J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):670-8. PubMed ID: 12486645 [TBL] [Abstract][Full Text] [Related]
33. [Comparative study of the treatment of Prinzmetal's angina with beta-blockers, amiodarone or calcium antagonists. Apropos of 91 cases]. Fauchier JP; Cosnay P; Neel C; Monpère C; Charbonnier B; Brochier M Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):567-73. PubMed ID: 6152139 [No Abstract] [Full Text] [Related]
34. Incidence of medication error associated with the use of beta-blockers in Pakistan. Nesar S; Shoaib MH; Yousuf RI; Rahim N; Muhammad IN Pak J Pharm Sci; 2014 May; 27(3):531-6. PubMed ID: 24811813 [TBL] [Abstract][Full Text] [Related]
35. [Drug treatment of patients with the chronic form of atrial fibrillation in counterindications for cardioversion (a review)]. Vorob'ev LP; Kaziulin AN Ter Arkh; 1985; 57(1):123-8. PubMed ID: 2858927 [No Abstract] [Full Text] [Related]
36. [Indications and limits for the use of beta-blockaders (beta-adrenergic inhibitors) in the treatment of hypertension]. Guédon J; Lucsko M; Chaignon M; Aubert Ph Sem Hop Ther; 1977 Feb; 53(2):83-6. PubMed ID: 16346 [No Abstract] [Full Text] [Related]
38. Response of left ventricular myocardial perfusion and cavity size to beta-blockade by acebutolol. Frick MH; Valle M; Korhola O; Hekali P; Riihimäki E Ann Clin Res; 1978 Apr; 10(2):66-70. PubMed ID: 28072 [TBL] [Abstract][Full Text] [Related]
39. Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease. Schrickel J; Bielik H; Yang A; Schwab JO; Shlevkov N; Schimpf R; Lüderitz B; Lewalter T Z Kardiol; 2003 Oct; 92(10):889-92. PubMed ID: 14579055 [TBL] [Abstract][Full Text] [Related]
40. [Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk]. Ducceschi V; Sarubbi B; Esposito R; Manzo G; Mayer MS; Santangelo L; Iacono A Cardiologia; 1995 May; 40(5):355-60. PubMed ID: 8529247 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]